NCT04674267Recruiting
Resilience and Equity in Aging, Cancer, and Health (REACH)
Resilience and Equity in Aging, Cancer, and Health (REACH): Promoting Physical Resilience and Cancer Care Equity for Adults Age 65 and Older Diagnosed With Gastrointestinal Malignancy
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 147 (estimated)
- First submitted
- 14 Dec 2020
- Start date
- 18 Jan 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Dana-Farber Cancer Institute
- NCT number
- NCT04674267
What you commit to
- Study type: Interventional
- Planned participants: 147
- From 18 Jan 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with psychiatric illness/social situations that would limit compliance with study requirements.
Age
- Patients less than age 65 at time of initial consultation appointment with DF/BWCC.
Other
- Patients who are not continuing care at DF/BWCC beyond first consult visit.
- Not proficient in English, Spanish, Haitian Creole, Portuguese, Traditional Chinese, Arabic, or Russian
- Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
Who the study is looking for
- Patients who are age 65+ at time of initial consult at DF/BWCC
- Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
- Continuing care at DF/BWCC beyond initial consult visit
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.